08:56 AM EST, 03/05/2024 (MT Newswires) -- Health care stocks were steady pre-bell Tuesday as the Health Care Select Sector SPDR Fund (XLV) and iShares Biotechnology ETF (IBB) were recently inactive.

Regenxbio ( RGNX ) was rallying past 38% after it reported new data about its investigational gene therapy RGX-202 showing "significantly increased" microdystrophin expression at dose level 2 with early evidence of strength and motor function improvement in a 12-year-old patient with Duchenne muscular dystrophy.